
Carol M. Koslow
Examiner (ID: 12920, Phone: (571)272-1371 , Office: P/1734 )
| Most Active Art Unit | 1734 |
| Art Unit(s) | 1734, 1754, 1793, 1755, 1108 |
| Total Applications | 5011 |
| Issued Applications | 4022 |
| Pending Applications | 258 |
| Abandoned Applications | 784 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12862237
[patent_doc_number] => 20180179253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => CELL PENETRATING PEPTIDES FOR INTRACELLULAR DELIVERY OF MOLECULES
[patent_app_type] => utility
[patent_app_number] => 15/802402
[patent_app_country] => US
[patent_app_date] => 2017-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5753
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15802402
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/802402 | Cell penetrating peptides for intracellular delivery of molecules | Nov 1, 2017 | Issued |
Array
(
[id] => 16176935
[patent_doc_number] => 20200223903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => Peptides Derived from Fibronectin with Improved Bioactivity and Reduced Susceptibility to Neutrophil Elastase Degradation
[patent_app_type] => utility
[patent_app_number] => 16/341686
[patent_app_country] => US
[patent_app_date] => 2017-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341686
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/341686 | Peptides derived from fibronectin with improved bioactivity and reduced susceptibility to neutrophil elastase degradation | Oct 11, 2017 | Issued |
Array
(
[id] => 13606909
[patent_doc_number] => 20180355003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => COMPOSITIONS FOR DETECTION, INHIBITION AND IMAGING OF INDOLEAMINE 2, 3-DIOXYGENASE 1 (IDO1) AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 15/721512
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15721512
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/721512 | Compositions for detection, inhibition and imaging of indoleamine 2, 3-dioxygenase 1 (IDO1) and methods of making and using same | Sep 28, 2017 | Issued |
Array
(
[id] => 14864851
[patent_doc_number] => 20190282667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => NOVEL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/337730
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33918
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16337730
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/337730 | NOVEL FORMULATIONS | Sep 28, 2017 | Pending |
Array
(
[id] => 14621923
[patent_doc_number] => 20190224329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => Incremental Dose Finding in Controlled-Release PTH Compounds
[patent_app_type] => utility
[patent_app_number] => 16/337803
[patent_app_country] => US
[patent_app_date] => 2017-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16337803
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/337803 | Incremental dose finding in controlled-release PTH compounds | Sep 27, 2017 | Issued |
Array
(
[id] => 12580941
[patent_doc_number] => 20180085476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => Activatable Membrane-Interacting Peptides and Methods of Use
[patent_app_type] => utility
[patent_app_number] => 15/700880
[patent_app_country] => US
[patent_app_date] => 2017-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25033
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15700880
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/700880 | Activatable membrane-interacting peptides and methods of use | Sep 10, 2017 | Issued |
Array
(
[id] => 14867981
[patent_doc_number] => 20190284232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => PEPTIDES AND PEPTIDE CONJUGATES FOR TREATING MENTAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/329062
[patent_app_country] => US
[patent_app_date] => 2017-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19533
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16329062
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/329062 | PEPTIDES AND PEPTIDE CONJUGATES FOR TREATING MENTAL DISORDERS | Sep 5, 2017 | Abandoned |
Array
(
[id] => 14501191
[patent_doc_number] => 20190194250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => PROCESSES FOR SEPARATING AGGREGATED PROTEINS FROM MONOMERIC PROTEINS IN A BIOLOGICAL SOLUTION
[patent_app_type] => utility
[patent_app_number] => 16/330304
[patent_app_country] => US
[patent_app_date] => 2017-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16330304
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/330304 | PROCESSES FOR SEPARATING AGGREGATED PROTEINS FROM MONOMERIC PROTEINS IN A BIOLOGICAL SOLUTION | Aug 29, 2017 | Pending |
Array
(
[id] => 12641016
[patent_doc_number] => 20180105503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => NEPRILYSIN INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/689168
[patent_app_country] => US
[patent_app_date] => 2017-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26235
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15689168
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/689168 | NEPRILYSIN INHIBITORS | Aug 28, 2017 | Abandoned |
Array
(
[id] => 14196647
[patent_doc_number] => 10265409
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-23
[patent_title] => Macromolecules
[patent_app_type] => utility
[patent_app_number] => 15/688780
[patent_app_country] => US
[patent_app_date] => 2017-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22430
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15688780
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/688780 | Macromolecules | Aug 27, 2017 | Issued |
Array
(
[id] => 13854075
[patent_doc_number] => 10188744
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-29
[patent_title] => Amphipathic peptide
[patent_app_type] => utility
[patent_app_number] => 15/688484
[patent_app_country] => US
[patent_app_date] => 2017-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 121
[patent_no_of_words] => 20969
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15688484
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/688484 | Amphipathic peptide | Aug 27, 2017 | Issued |
Array
(
[id] => 12588879
[patent_doc_number] => 20180088122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => USE OF CD36 TO IDENTIFY CANCER SUBJECTS FOR TREATMENT
[patent_app_type] => utility
[patent_app_number] => 15/684639
[patent_app_country] => US
[patent_app_date] => 2017-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15684639
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/684639 | Use of CD36 to identify cancer subjects for treatment | Aug 22, 2017 | Issued |
Array
(
[id] => 16459401
[patent_doc_number] => 10842728
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => Light-absorbing compositions and methods of use
[patent_app_type] => utility
[patent_app_number] => 15/682388
[patent_app_country] => US
[patent_app_date] => 2017-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 28218
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15682388
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/682388 | Light-absorbing compositions and methods of use | Aug 20, 2017 | Issued |
Array
(
[id] => 12785821
[patent_doc_number] => 20180153776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => APPLICATION AND USES OF PRG4 AND THERAPEUTIC MODULATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/676433
[patent_app_country] => US
[patent_app_date] => 2017-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15676433
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/676433 | Application and uses of PRG4 and therapeutic modulation thereof | Aug 13, 2017 | Issued |
Array
(
[id] => 14406781
[patent_doc_number] => 20190169234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => PEPTIDE INHIBITORS OF PHOSPHOGLYCERATE MUTASE AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/324424
[patent_app_country] => US
[patent_app_date] => 2017-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16324424
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/324424 | Peptide inhibitors of phosphoglycerate mutase and methods of use | Aug 9, 2017 | Issued |
Array
(
[id] => 17020986
[patent_doc_number] => 20210244857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => PEPTIDE-COATED CALCIUM PHOSPHATE PARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/319849
[patent_app_country] => US
[patent_app_date] => 2017-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16319849
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/319849 | PEPTIDE-COATED CALCIUM PHOSPHATE PARTICLES | Jul 24, 2017 | Pending |
Array
(
[id] => 16941080
[patent_doc_number] => 11053301
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-06
[patent_title] => Methods and compositions relating to covalently circularized nanodiscs
[patent_app_type] => utility
[patent_app_number] => 16/317924
[patent_app_country] => US
[patent_app_date] => 2017-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 48
[patent_no_of_words] => 24640
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16317924
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/317924 | Methods and compositions relating to covalently circularized nanodiscs | Jul 16, 2017 | Issued |
Array
(
[id] => 12000301
[patent_doc_number] => 20170304456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'FAST DISSOLVING PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/644933
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8974
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15644933
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/644933 | FAST DISSOLVING PHARMACEUTICAL COMPOSITION | Jul 9, 2017 | Abandoned |
Array
(
[id] => 11977567
[patent_doc_number] => 20170281722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'Treatment of Constipation-Predominant Irritable Bowel Syndrome'
[patent_app_type] => utility
[patent_app_number] => 15/624862
[patent_app_country] => US
[patent_app_date] => 2017-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 10571
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 45
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15624862
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/624862 | Treatment of Constipation-Predominant Irritable Bowel Syndrome | Jun 15, 2017 | Abandoned |
Array
(
[id] => 11962111
[patent_doc_number] => 20170266263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'METHODS FOR INCREASING INTRACELLULAR ACTIVITY OF HSP70'
[patent_app_type] => utility
[patent_app_number] => 15/600407
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 38226
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15600407
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/600407 | Methods for increasing intracellular activity of Hsp70 | May 18, 2017 | Issued |